ScholarIQanswers from OpenAlex & ORCID
Johan M. Kros
ResearcherPublications, citations & collaboration network
Johan M. Kros is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Johan M. Kros have?
ScholarIQindexed works
Johan M. Kros has 615 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Johan M. Kros have?
ScholarIQcitation count
Johan M. Kros has 35,168 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Johan M. Kros?
ScholarIQh-index
Johan M. Kros has an h-index of 89 in OpenAlex.
What is the i10-index of Johan M. Kros?
ScholarIQi10-index
Johan M. Kros has an i10-index of 260 in OpenAlex.
What is the ORCID of Johan M. Kros?
ScholarIQorcid
The ORCID for Johan M. Kros is on the source record.
What is the OpenAlex record for Johan M. Kros?
ScholarIQopenalex
The OpenAlex for Johan M. Kros is on the source record.
What are the most-cited papers on Johan M. Kros?
ScholarIQmost cited works
Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis
Ingrid M.B.H. van de Laar, Rogier A. Oldenburg, Gerard Pals, Jolien W. Roos‐Hesselink, Bianca M. de Graaf, Judith M.A. Verhagen, Yvonne M. Hoedemaekers, Rob Willemsen, Lies‐Anne Severijnen, Hanka Venselaar, Gert Vriend, Peter M. T. Pattynama, Margriet Collée, Daniëlle Majoor‐Krakauer, Don Poldermans, Ingrid M.E. Frohn-Mulder, Dimitra Micha, Janneke Timmermans, Yvonne Hilhorst‐Hofstee, Sita Bierma‐Zeinstra, Patrick J. Willems, Johan M. Kros, E.H. Oei, Ben A. Oostra, Marja W. Wessels, Aida M. Bertoli‐Avella
Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
Martin J. van den Bent, Alba A. Brandes, R. Rampling, Mathilde C.M. Kouwenhoven, Johan M. Kros, Alain Carpentier, Paul M. Clément, M. Frénay, Mario Campone, Jean‐François Baurain, Jean-Paul Armand, Martin Taphoorn, Alicia Tosoni, Heidemarie Kletzl, Barbara Klughammer, Denis Lacombe, Thierry Gorlia
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
Eric M. Thompson, Thomas Hielscher, Éric Bouffet, Marc Remke, Betty Luu, Sridharan Gururangan, Roger E. McLendon, Darell D. Bigner, Eric Lipp, Sébastien Perreault, Yoon-Jae Cho, Gerald A. Grant, Seung‐Ki Kim, Ji Yeoun Lee, Amulya A. Nageswara Rao, Caterina Giannini, Kay Ka Wai Li, Ho‐Keung Ng, Yu Yao, Toshihiro Kumabe, Teiji Tominaga, Wiesława Grajkowska, Marta Perek‐Polnik, David C.Y. Low, Wan Tew Seow, Kenneth Tou En Chang, Jaume Mora, Ian F. Pollack, Ronald L. Hamilton, Sarah Leary, Andrew S. Moore, Wendy J. Ingram, Andrew R. Hallahan, Anne Jouvet, Michelle Fèvre‐Montange, Alexandre Vasiljevic, Cécile Faure‐Conter, Tomoko Shofuda, Naoki Kagawa, Naoya Hashimoto, Nada Jabado, Alexander G. Weil, Tenzin Gayden, Takafumi Wataya, Tarek Shalaby, Michael A. Grotzer, Karel Zitterbart, Jaroslav Štěrba, Leoš Křen, Tibor Hortobágyi, Álmos Klekner, László Bognár, Tímea Pócza, Péter Hauser, Ulrich Schüller, Shin Jung, Woo‐Youl Jang, Pim J. French, Johan M. Kros, Marie‐Lise C. van Veelen, Luca Massimi, Jeffrey R. Leonard, Joshua B. Rubin, Rajeev Vibhakar, Lola B. Chambless, Michael K. Cooper, Reid C. Thompson, Cláudia C. Faria, Alice Carvalho, Sofia Nunes, José Pimentel, Xing Fan, Karin M. Muraszko, Enrique López‐Aguilar, David Lyden, Livia Garzia, David Shih, Noriyuki Kijima, Christian Schneider, Jennifer Adamski, Paul A. Northcott, Marcel Kool, David Jones, Jennifer A. Chan, Ana Nikolić, Maria Luisa Garrè, Erwin G. Van Meir, Satoru Osuka, Jeffrey J. Olson, Arman Jahangiri, Brandyn Castro, Nalin Gupta, William A. Weiss, Iska Moxon‐Emre, Donald Mabbott, Álvaro Lassaletta, Cynthia Hawkins, Uri Tabori, James M. Drake, Abhaya V. Kulkarni